Literature DB >> 30948511

Transforming growth factor-β (TGF-β)-induced up-regulation of TGF-β receptors at the cell surface amplifies the TGF-β response.

Dana Duan1,2, Rik Derynck3,2,4.   

Abstract

Functional activation of the transforming growth factor-β (TGF-β) receptors (TGFBRs) is carefully regulated through integration of post-translational modifications, spatial regulation at the cellular level, and TGFBR availability at the cell surface. Although the bulk of TGFBRs resides inside the cells, AKT Ser/Thr kinase (AKT) activation in response to insulin or other growth factors rapidly induces transport of TGFBRs to the cell surface, thereby increasing the cell's responsiveness to TGF-β. We now demonstrate that TGF-β itself induces a rapid translocation of its own receptors to the cell surface and thus amplifies its own response. This mechanism of response amplification, which hitherto has not been reported for other cell-surface receptors, depended on AKT activation and TGF-β type I receptor kinase. In addition to an increase in cell-surface TGFBR levels, TGF-β treatment promoted TGFBR internalization, suggesting an overall amplification of TGFBR cycling. The TGF-β-induced increase in receptor presentation at the cell surface amplified TGF-β-induced SMAD family member (SMAD) activation and gene expression. Furthermore, bone morphogenetic protein 4 (BMP-4), which also induces AKT activation, increased TGFBR levels at the cell surface, leading to enhanced autocrine activation of TGF-β-responsive SMADs and gene expression, providing context for the activation of TGF-β signaling in response to BMP during development. In summary, our results indicate that TGF-β- and BMP-induced activation of low levels of cell surface-associated TGFBRs rapidly mobilizes additional TGFBRs from intracellular stores to the cell surface, increasing the abundance of cell-surface TGFBRs and cells' responsiveness to TGF-β signaling.
© 2019 Duan and Derynck.

Entities:  

Keywords:  Akt PKB; SMAD transcription factor; Smad activation; autocrine signaling; bone morphogenetic protein (BMP); cell-surface receptor; transcription regulation

Mesh:

Substances:

Year:  2019        PMID: 30948511      PMCID: PMC6544840          DOI: 10.1074/jbc.RA118.005763

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

Review 1.  Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility.

Authors:  Erine H Budi; Dana Duan; Rik Derynck
Journal:  Trends Cell Biol       Date:  2017-05-25       Impact factor: 20.808

Review 2.  TGF-β Family Signaling in Mesenchymal Differentiation.

Authors:  Ingo Grafe; Stefanie Alexander; Jonathan R Peterson; Taylor Nicholas Snider; Benjamin Levi; Brendan Lee; Yuji Mishina
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

3.  Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes.

Authors:  Shixiong Tan; Yvonne Ng; David E James
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

4.  The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor.

Authors:  S Maudsley; K L Pierce; A M Zamah; W E Miller; S Ahn; Y Daaka; R J Lefkowitz; L M Luttrell
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Specific activation of mitogen-activated protein kinase by transforming growth factor-beta receptors in lipid rafts is required for epithelial cell plasticity.

Authors:  Wei Zuo; Ye-Guang Chen
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

6.  Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline.

Authors:  Ying Xi; Kevin Tan; Alexis N Brumwell; Steven C Chen; Yong-Hyun Kim; Thomas J Kim; Ying Wei; Harold A Chapman
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

7.  Human Smad3 and Smad4 are sequence-specific transcription activators.

Authors:  L Zawel; J L Dai; P Buckhaults; S Zhou; K W Kinzler; B Vogelstein; S E Kern
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

8.  ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation.

Authors:  Baby Periyanayaki Muthusamy; Erine H Budi; Yoko Katsuno; Matthew K Lee; Susan M Smith; Amer M Mirza; Rosemary J Akhurst; Rik Derynck
Journal:  PLoS Biol       Date:  2015-12-17       Impact factor: 8.029

9.  TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.

Authors:  Young-Woong Kim; Jinah Park; Hyun-Ju Lee; So-Young Lee; Seong-Jin Kim
Journal:  Biochem J       Date:  2012-08-01       Impact factor: 3.857

10.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.

Authors:  A Erlebacher; R Derynck
Journal:  J Cell Biol       Date:  1996-01       Impact factor: 10.539

View more
  22 in total

1.  Species-specific sensitivity to TGFβ signaling and changes to the Mmp13 promoter underlie avian jaw development and evolution.

Authors:  Spenser S Smith; Daniel Chu; Tiange Qu; Jessye A Aggleton; Richard A Schneider
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

2.  N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells.

Authors:  Jiexin Li; Feng Chen; Yanxi Peng; Ziyan Lv; Xinyao Lin; Zhuojia Chen; Hongsheng Wang
Journal:  Cells       Date:  2020-01-25       Impact factor: 6.600

Review 3.  Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective.

Authors:  Sergio Liarte; Ángel Bernabé-García; Francisco J Nicolás
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

4.  Integration of TGF-β-induced Smad signaling in the insulin-induced transcriptional response in endothelial cells.

Authors:  Erine H Budi; Steven Hoffman; Shaojian Gao; Ying E Zhang; Rik Derynck
Journal:  Sci Rep       Date:  2019-11-18       Impact factor: 4.379

5.  Fluid shear stress generates a unique signaling response by activating multiple TGFβ family type I receptors in osteocytes.

Authors:  David A Monteiro; Neha S Dole; J Luke Campos; Serra Kaya; Charles A Schurman; Cassandra D Belair; Tamara Alliston
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.191

6.  Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation.

Authors:  Stephanie Dobersch; Karla Rubio; Indrabahadur Singh; Stefan Günther; Johannes Graumann; Julio Cordero; Rafael Castillo-Negrete; Minh Bao Huynh; Aditi Mehta; Peter Braubach; Hector Cabrera-Fuentes; Jürgen Bernhagen; Cho-Ming Chao; Saverio Bellusci; Andreas Günther; Klaus T Preissner; Sita Kugel; Gergana Dobreva; Malgorzata Wygrecka; Thomas Braun; Dulce Papy-Garcia; Guillermo Barreto
Journal:  Nat Commun       Date:  2021-02-16       Impact factor: 14.919

Review 7.  Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis.

Authors:  Hendrik Ungefroren
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

8.  Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.

Authors:  Xiaolin Zhang; Xiuli Shao; Ruijia Zhang; Rongli Zhu; Rui Feng
Journal:  Clin Epigenetics       Date:  2021-01-06       Impact factor: 6.551

9.  Effect of expansion media and fibronectin coating on growth and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells.

Authors:  Valentina Basoli; Elena Della Bella; Eva Johanna Kubosch; Mauro Alini; Martin J Stoddart
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

Review 10.  AGAP2: Modulating TGFβ1-Signaling in the Regulation of Liver Fibrosis.

Authors:  Amaia Navarro-Corcuera; Eduardo Ansorena; Cristina Montiel-Duarte; María J Iraburu
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.